Procuritas Partners AB, the Sweden based private equity firm, through its Procuritas Capital Investor VII fund, has acquired Precision BioLogic Inc., the Canada based niche player in the coagulation diagnostics market focused on FDA cleared reagents and frozen plasmas, for an undisclosed amount.
- Target – Precision Biologic inc.
- Buyer – Procuritas Partners AB
- Seller – Shareholders